Article Details

Snell & Wilmer Advises Biotechnology Company Trawsfynydd Therapeutics, Inc. in Merger ...

Retrieved on: 2024-04-02 23:06:19

Tags for this article:

Click the tags to see associated articles and topics

Snell & Wilmer Advises Biotechnology Company Trawsfynydd Therapeutics, Inc. in Merger .... View article details on HISWAI: https://www.swlaw.com/client-news/snell-wilmer-advises-biotechnology-company-trawsfynydd-therapeutics-inc-in-merger-with-onconova-therapeutics-inc

Summary

The article discusses Snell & Wilmer's representation of Trawsfynydd Therapeutics in its merger with Onconova Therapeutics, focusing on antiviral development for COVID-19 and targeting financial markets and investment through equity securities like NASDAQ.

Article found on: www.swlaw.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up